Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2018 Apr;37(4):875-884.
doi: 10.1007/s10067-018-4062-x. Epub 2018 Mar 10.

Anti-neutrophil cytoplasmic antibodies and their clinical significance

Affiliations
Review

Anti-neutrophil cytoplasmic antibodies and their clinical significance

Supaporn Suwanchote et al. Clin Rheumatol. 2018 Apr.

Abstract

Anti-neutrophil cytoplasmic antibodies (ANCA) are a group of autoantibodies that cause systemic vascular inflammation by binding to target antigens of neutrophils. These autoantibodies can be found in serum from patients with systemic small-vessel vasculitis and they are considered as a biomarker for ANCA-associated vasculitis (AAV). A conventional screening test to detect ANCA in the serum is indirect immunofluorescence study, and subsequently confirmed by enzyme-linked immunosorbent assay. A positive staining of ANCA can be classified into three main categories based on the staining patterns: cytoplasmic, perinuclear, and atypical. Patients with granulomatosis with polyangiitis (GPA) mostly have a positive cytoplasmic staining pattern (c-ANCA) whilst a perinuclear pattern (p-ANCA) is more common in microscopic polyangiitis (MPA) and eosinophilic granulomatosis with polyangiitis (EGPA) patients. Atypical pattern (a-ANCA) is rarely seen in patients with systemic small-vessel vasculitis but it can be found in other conditions. Here, techniques for ANCA detection, ANCA staining patterns and their clinical significances are reviewed.

Keywords: ANCA; ANCA staining pattern; ANCA-associated vasculitis.

PubMed Disclaimer

Comment in

Similar articles

Cited by

References

    1. Ann Rheum Dis. 2010 Nov;69(11):1934-9 - PubMed
    1. Lupus. 2016 Jul;25(8):917-24 - PubMed
    1. Arthritis Rheumatol. 2014 Jun;66(6):1672-7 - PubMed
    1. Semin Nephrol. 2017 Sep;37(5):418-435 - PubMed
    1. Lancet. 2006 Jul 29;368(9533):404-18 - PubMed

MeSH terms

Substances

LinkOut - more resources